Skip to Main content Skip to Navigation
Journal articles

Somatostatin receptor scintigraphy screening in advanced hepatocarcinoma: A multi-center French study.

Abstract : BACKGROUND: Somatostatin receptor scintigraphy (SRS) has been reported for receptor (SSTR) screening in advanced hepatocarcinoma (aHC) prior to somatostatin analogue treatment. AIMS: To evaluate SSTR screening with SRS in aHC patients. RESULTS: Seventy aHC patients (63 men) aged 65 +/- 11 y were included, with alcohol, viral or other causes cirrhosis in 35 (50%), 23 (33%), 12 (17%) cases respectively. CLIP score was 2.7 +/- 1.7, with more than three nodules in 37 (53%) cases. Largest nodule measured 7.6 +/- 4.5 cm. Median alpha-fetoprotein was 574 UI/mL. SRS was positive in 25/70 (35.7%) livers and 7/17 (41.2%) metastatic sites. Positive SRS patients differed from others for tumor size (9.2 +/- 4 vs. 6.7 +/- 4.6 cm, p = 0.03), prothrombin time (PT) (75.2 +/- 15.2 vs. 61.9 +/- 19%, p = 0.005), albumin (34.1 +/- 5.9 vs. 30.5 +/- 7.2 g/L, p = 0.04) and Child-Pugh (6.7 +/- 1.8 vs. 7.7 +/- 2.3, p = 0.04). After multivariate analysis, only PT was associated with positive SRS (p = 0.028). Immunohistochemistry was positive for SSTR2s in 6/7 tumors (SRS uptake in 5/6 cases). METHODS: SRS was performed prior treatment, with images at 4, 24 and 48 h. For seven tumors, SSTR2 subtype was detected immunohistochemically. CONCLUSIONS: In advanced hepatocarcinoma, we report SRS uptake in 35.7% of livers and 41.2% of metastatic sites. SRS value in screening patients for somatostatin analogue treatment remains to be assessed.
Document type :
Journal articles
Complete list of metadatas

https://www.hal.inserm.fr/inserm-00419507
Contributor : Marie Francoise Simon <>
Submitted on : Thursday, September 24, 2009 - 10:41:10 AM
Last modification on : Wednesday, August 19, 2020 - 11:16:35 AM

Identifiers

  • HAL Id : inserm-00419507, version 1
  • PUBMED : 19738430

Citation

Eric Nguyen-Khac, Isabelle Ollivier, Thomas Aparicio, Véronique Moullart, Alexis Hugentobler, et al.. Somatostatin receptor scintigraphy screening in advanced hepatocarcinoma: A multi-center French study.. Cancer Biology and Therapy, Taylor & Francis, 2009, 8 (21), pp.2033-9. ⟨inserm-00419507⟩

Share

Metrics

Record views

762